
Ordering Information
| Product Name | Catalog # | UNIT | Price | Qty | FAVORITES | |
Stim1 CRISPR/Cas9 KO Plasmid (h) | sc-401311 | 20 µg | $397.00 |
STIM1 encodes stromal interaction molecule 1 (Stim1), an endoplasmic reticulum Ca2+ sensor that initiates store-operated calcium entry by coupling ER Ca2+ depletion to activation of ORAI channels at ER–plasma membrane junctions. This Ca2+ influx regulates NFAT-dependent transcription, cytoskeletal remodeling, secretion, and broader calcium-dependent signaling networks controlling proliferation and stress responses. STIM1-dependent pathways are central to immune cell activation and other excitable and non-excitable cell functions, linking altered calcium homeostasis to immunological phenotypes and additional pathophysiology. In human disease biology, dysregulated STIM1 signaling is frequently studied in the context of aberrant Ca2+ entry and downstream transcriptional programs that impact cell-state decisions.
Stim1 CRISPR/Cas9 KO Plasmid (h) is a pool of plasmids designed for targeted disruption of the STIM1 gene in human cell lines. Each plasmid co-expresses a unique single guide RNA (sgRNA) targeting a distinct site within the STIM1 together with the Streptococcus pyogenes Cas9 nuclease. The plasmids also encode GFP, allowing fluorescent identification and enrichment of successfully transfected cells by fluorescence microscopy or flow cytometry.
The multi-guide design increases the likelihood of generating insertions or deletions (indels) that disrupt the STIM1 open reading frame following Cas9-mediated double-strand break formation. DNA breaks introduced by the CRISPR/Cas9 system are repaired through endogenous non-homologous end joining (NHEJ) pathways, frequently resulting in frameshift mutations that abolish Stim1 protein expression.
This CRISPR knockout system enables efficient generation of STIM1-deficient cell models for investigation of Stim1 signaling, functional genomics studies, cancer biology research, and evaluation of therapeutic responses in human cell lines.
CRISPRs +/- HDRs
For Research Use Only. Not Intended for Diagnostic or Therapeutic Use.